Andrew D.C. LaFrence

Insider Reports History

Entity
Individual
Location
C/O Vyant Bio, Inc., 201 Route 17 North, 2 Nd Floor, Rutherford, NJ
Signature
/s/ Andrew D.C. LaFrence
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew D.C. LaFrence:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NORTECH SYSTEMS INC CHIEF FINANCIAL OFFICER Options 40K $362K $9.04 Dec 4, 2023 Direct
KORU Medical Systems, Inc. Chief Financial Officer Options to Purchase Common Stock 300K Jul 15, 2023 Direct
Vyant Bio, Inc. Chief Financial Officer Stock option (right to buy) 110K Mar 15, 2022 Direct
KORU Medical Systems, Inc. Chief Financial Officer Common Stock 0 $2.37 Jul 10, 2023 Direct

Insider Reports Filed by Andrew D.C. LaFrence

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NSYS NORTECH SYSTEMS INC Dec 4, 2023 1 $362K 4 Dec 5, 2023 CHIEF FINANCIAL OFFICER
NSYS NORTECH SYSTEMS INC Dec 1, 2023 0 $0 3 Dec 5, 2023 CHIEF FINANCIAL OFFICER
KRMD KORU Medical Systems, Inc. Jul 15, 2023 1 $0 4 Jul 18, 2023 Chief Financial Officer
KRMD KORU Medical Systems, Inc. Jul 10, 2023 0 $0 3 Jul 18, 2023 Chief Financial Officer
VYNT Vyant Bio, Inc. Mar 15, 2022 1 $0 4 Mar 17, 2022 Chief Financial Officer
VYNT Vyant Bio, Inc. Nov 23, 2021 1 $10K 4/A Dec 29, 2021 Chief Financial Officer
VYNT Vyant Bio, Inc. May 20, 2021 1 $9.84K 4 May 21, 2021 Chief Financial Officer
VYNT Vyant Bio, Inc. Mar 30, 2021 2 $0 4/A Jul 13, 2021 Chief Financial Officer